← Back to Screener
Aspire Biopharma Holdings, Inc. Common Stock (ASBP)
Price$0.26
Favorite Metrics
Price vs S&P 500 (26W)-106.70%
Price vs S&P 500 (4W)-71.93%
Market Capitalization$1.36M
All Metrics
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.60
Price vs S&P 500 (YTD)-99.03%
EPS (TTM)$-4.67
10-Day Avg Trading Volume3.85M
EPS Excl Extra (TTM)$-4.67
EPS (Annual)$-60.83
ROI (Annual)22.79%
Cash / Share (Quarterly)$1.57
ROA (Last FY)-186.73%
EBITD / Share (TTM)$-2.16
Cash Flow / Share (Annual)$-10.58
P/B Ratio15.06x
Net Interest Coverage (TTM)-35.56x
ROA (TTM)-951.07%
EPS Incl Extra (Annual)$-60.83
Current Ratio (Annual)0.00x
Quick Ratio (Quarterly)0.14x
3-Month Avg Trading Volume1.26M
52-Week Price Return-98.78%
52-Week High$35.00
EPS Excl Extra (Annual)$-60.83
26-Week Price Return-97.96%
Quick Ratio (Annual)0.00x
13-Week Price Return-88.57%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)0.17x
Enterprise Value$8.032
Cash / Share (Annual)$0.01
3-Month Return Std Dev230.11%
ROE (Last FY)22.80%
Net Interest Coverage (Annual)-9.51x
EPS Basic Excl Extra (Annual)$-60.83
Total Debt / Equity (Quarterly)59.33x
EPS Incl Extra (TTM)$-4.67
ROI (TTM)-29.72%
Revenue / Share (Annual)$0.00
Price vs S&P 500 (52W)-133.87%
Year-to-Date Return-94.89%
5-Day Price Return-76.34%
EPS Normalized (Annual)$-60.83
Month-to-Date Return-73.82%
EBITD / Share (Annual)$-59.17
EPS Basic Excl Extra (TTM)$-4.67
Price vs S&P 500 (13W)-91.44%
Beta0.37x
ROE (TTM)-39.70%
52-Week Low$0.25
Industry Peers — Pharmaceuticals(309)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ASBPAspire Biopharma Holdings, Inc. Common Stock | — | — | — | — | $0.26 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Aspire Biopharma Holdings Inc develops nanotechnology-based drug delivery systems designed to improve medication absorption while reducing gastrointestinal exposure. The company's platform targets pain and inflammation management, with applications to opioid-related therapeutics. Its proprietary delivery mechanisms aim to enhance the efficacy and safety profiles of pharmaceutical compounds.